← back to search

Anders Engeland

Norwegian Institute of Public Health ·
Area of research
Public Health, Environmental and Occupational Health · Oncology
Research interest
Research interests include Cancer Risks and Factors, Pregnancy and Medication Impact, Maternal Mental Health During Pregnancy and Postpartum, and Birth, Development, and Health.
h-index
66
citations
13,090
works
269
NIH funding
primary concept
email

Recent publications

ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases
The Lancet Psychiatry 2023cited by 67position: middledoi
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations
Annals of Neurology 2022cited by 68position: middledoi
Labor epidural analgesia and subsequent risk of offspring autism spectrum disorder and attention-deficit/hyperactivity disorder: a cross-national cohort study of 4.5 million individuals and their siblings
American Journal of Obstetrics and Gynecology 2022cited by 21position: middledoi
Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population‐based cohort study
Pharmacoepidemiology and Drug Safety 2021cited by 5position: firstdoi
Antipsychotic drug use in pregnancy: A multinational study from ten countries
Schizophrenia Research 2020cited by 53position: middledoi
β-Blocker Use in Pregnancy and the Risk for Congenital Malformations
Annals of Internal Medicine 2018cited by 94position: middledoi
β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
Science 2017cited by 434position: middledoi
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations
JAMA Psychiatry 2017cited by 140position: middledoi
The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures
European Journal of Clinical Pharmacology 2017cited by 10position: middledoi
Prescribing of Antidiabetic Medicines before, during and after Pregnancy: A Study in Seven European Regions
PLoS ONE 2016cited by 106position: middledoi
Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark
PLoS ONE 2016cited by 67position: middledoi
Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study
BJOG An International Journal of Obstetrics & Gynaecology 2016cited by 42position: middledoi
Asthma medication prescribing before, during and after pregnancy: a study in seven European regions
BMJ Open 2016cited by 29position: middledoi
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design
BMJ 2015cited by 186position: middledoi
Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions
Pharmacoepidemiology and Drug Safety 2015cited by 41position: middledoi
Pregnancy Prevention Programs in Europe : A Multidisciplinary Approach to Isotretinoin Use by Women
University of Groningen research database (University of Groningen / Centre for Information Technology) 2015cited by 0position: middle
Antiepileptic Drug Use before, during and after Pregnancy : A Study in 7 European Regions
Data Archiving and Networked Services (DANS) 2014cited by 1position: middle
Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination
New England Journal of Medicine 2013cited by 298position: middledoi
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
JAMA 2013cited by 101position: middledoi
Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women
Cancer Causes & Control 2013cited by 60position: middledoi
Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination
Obstetrical & Gynecological Survey 2013cited by 16position: middledoi
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me–Can)
Gynecologic Oncology 2012cited by 66position: middledoi
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can)
British Journal of Dermatology 2012cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kari Klungsøyr · University of Ferrara11 papers (2014–2023)Kari Furu · Norwegian Institute of Public Health9 papers (2013–2022)Helen Dolk · University of Ferrara8 papers (2014–2017)Daniel Thayer · Swansea University8 papers (2014–2017)Ester Garne · University of Ferrara7 papers (2014–2017)Helga Zoëga · University of Iceland7 papers (2013–2023) · 6 papers (2014–2017)Amanda J. Neville · University of Ferrara6 papers (2014–2017)Aurora Puccini · University of Ferrara6 papers (2014–2017)Anne Vinkel Hansen · University of California, Davis6 papers (2015–2017)Mika Gissler · University College London6 papers (2013–2022)Anna Pierini · University of Ferrara6 papers (2014–2017)Randi Selmer · Norwegian Institute of Public Health6 papers (2012–2022) · 6 papers (2014–2017)Sue Jordan · Swansea University6 papers (2014–2017)Mette Nørgaard · Aarhus University5 papers (2013–2022)H Bos · 's Heeren Loo4 papers (2014–2017)Anne‐Marie Nybo Andersen · University of Copenhagen4 papers (2014–2016)Kristjana Einarsdóttir · The University of Western Australia4 papers (2017–2022)Helle Kieler · Karolinska University Hospital4 papers (2013–2018)